Reita, D.; Pabst, L.; Pencreach, E.; Guérin, E.; Dano, L.; Rimelen, V.; Voegeli, A.-C.; Vallat, L.; Mascaux, C.; Beau-Faller, M.
Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. Cancers 2022, 14, 1321.
https://doi.org/10.3390/cancers14051321
AMA Style
Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli A-C, Vallat L, Mascaux C, Beau-Faller M.
Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. Cancers. 2022; 14(5):1321.
https://doi.org/10.3390/cancers14051321
Chicago/Turabian Style
Reita, Damien, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux, and Michèle Beau-Faller.
2022. "Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance" Cancers 14, no. 5: 1321.
https://doi.org/10.3390/cancers14051321
APA Style
Reita, D., Pabst, L., Pencreach, E., Guérin, E., Dano, L., Rimelen, V., Voegeli, A.-C., Vallat, L., Mascaux, C., & Beau-Faller, M.
(2022). Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. Cancers, 14(5), 1321.
https://doi.org/10.3390/cancers14051321
